Chicago, September 3, 2014
Easter Seals has received a $300,000 grant from the CVS Caremark Charitable Trust to advance clinically proven brain fitness training through Easter Seals programs for older adults and veterans in New Hampshire as well as for young adults with autism spectrum disorder in Missouri. Outcomes for program participants are expected to include improved memory, attention, focus, brain speed, mood and confidence as well as social cognition.
Nearly one billion people live with neurological disorders and related conditions according to the World Health Organization. Easter Seals has a nearly 100-year history of helping people improve their brain function when they need to learn new skills – or re-learn old ones – due to a developmental disability, injury, illness or the aging process. Through a partnership with Posit Science, the leading provider of clinically proven brain fitness training exercises, Easter Seals is advancing the use of these tools to enhance brain function among a variety of populations, bringing research to practice at the community level through these programs in New Hampshire and Missouri.
“Imagine a world where people could protect, rehabilitate, improve or enhance brain function and better manage or address chronic conditions like dementia, traumatic brain injury, autism spectrum disorder, depression, addiction and many more,” said James E. Williams, Jr., president and chief executive officer, Easter Seals. “This is the vision behind Easter Seals Brain Health Center. We are grateful to the CVS Caremark Charitable Trust for its support through which older adults, veterans and young adults on the autism spectrum have the opportunity to benefit from brain health tools which have proven successful in clinical trials.”
“Through our foundation we are committed to supporting innovative programs which advance our purpose of helping people on their path to better health and help to improve health outcomes,” said Eileen Howard Boone, President, CVS Caremark Charitable Trust. “The Easter Seals Brain Health Center promises to deliver 21st century solutions to people living with a variety of neurological disorders and related conditions which promise to help them achieve positive outcomes which lead to better health, wellness and quality of life.”
Since selecting Easter Seals as a national partner in its All Kids Can® program more than eight years ago, CVS Caremark, its private foundation and its associates nationwide have contributed nearly $16 million to support Easter Seals services which help put children and adults with autism and other disabilities on their path to better health.
About Easter Seals
Easter Seals is the leading non-profit provider of services for individuals with autism, developmental disabilities, physical disabilities and other special needs. For nearly 100 years, Easter Seals has been offering help and hope to children and adults living with disabilities, and to the families who love them. Through therapy, training, education and support services, Easter Seals creates life-changing solutions so that people with disabilities can live, learn, work and play. To learn more about Easter Seals and services in communities nationwide, visit www.easterseals.com
About the CVS Caremark Charitable Trust
The CVS Caremark Charitable Trust, Inc. is a private foundation created by CVS Caremark Corporation (NYSE: CVS). CVS Caremark is the largest pharmacy health care provider in the nation. The Trust's mission is to provide funding for health care, education, disaster relief and community involvement initiatives in CVS Caremark communities. General information about CVS Caremark is available through the Investor Relations portion of the Company's Web site atinfo.cvscaremark.com/investors.
About Posit Science
Posit Science is the leading provider of clinically proven brain fitness training. Its exercises, available online at www.BrainHQ.com, have been shown to significantly improve brain speed, attention, memory and numerous standard measures of quality of life in multiple studies published in more than 70 peer-reviewed articles in leading science and medical journals. The company’s science team is led by renowned neuroscientist Michael Merzenich, PhD.